Mymetics Corporation

Industry

  • Biotechnology
    • Nanotechnology, Chips, etc.
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery

Other Names/Subsidiaries

  • Virosome Biologicals
  • Mymetics SA
  • Bestewil Holding
See more in Biomedtracker

Latest on Mymetics Corporation

Scrip

Astellas Builds Vaccine Portfolio With Affinivax Pneumococcal Candidate

 
• By Ian Haydock

Astellas Pharma Inc. is paying $10m upfront to acquire exclusive worldwide rights to develop and commercialize a novel pneumococcal disease vaccine developed by Affinivax Inc. using the US ventu

Pink Sheet

Astellas Regains Japan Losses With Xtandi Expansion

 
• By Daniel Poppy

Astellas Pharma Inc. views prostate cancer therapy Xtandi (enzalutamide) as a growth driver as it reorganizes its R&D structure to encourage innovation in oncology. In a Feb. 3 earnings call, Aste

In Vivo

Deals Shaping The Medical Industry, February 2014

IN VITRO DIAGNOSTICS Alliances NovaMedica LLC Venter Pharma SL Russian specialty pharmaco NovaMedica LLC received exclusive rights to commercialize Spanish firm Venter Pharma SL ’s lactose into

Scrip

Astellas Regains Japan Losses With Xtandi Expansion

 
• By Daniel Poppy

Astellas Pharma Inc. views prostate cancer therapy Xtandi (enzalutamide) as a growth driver as it reorganizes its R&D structure to encourage innovation in oncology. In a Feb. 3 earnings call, Aste